Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Hepatocyte nuclear transcriptional machinery" is a non-canonical, umbrella phrase that generally refers to the network of nuclear transcription factors, coactivators, corepressors, and associated nuclear receptors that control gene expression in hepatocytes. This machinery includes hepatocyte-enriched transcription factors such as hepatocyte nuclear factor 4 alpha (HNF4α), which is a highly conserved orphan nuclear receptor (NR2A1) and a master regulator of hepatic differentiation and function. HNF4α and related factors bind specific DNA elements in promoters/enhancers of liver-specific genes and recruit coactivators or corepressors to regulate chromatin state and transcription. They control broad hepatic programs including glycolysis, gluconeogenesis, fatty acid and bile acid metabolism, urea production, apolipoprotein synthesis, coagulation factors, and drug-metabolizing enzymes, and they also influence hepatocyte proliferation, cell cycle, apoptosis, and epithelial–mesenchymal transition. Because the term does not define one molecule but rather an interacting set of nuclear transcription factors and complexes, it is not suitable as a single therapeutic target entry; instead, individual components such as hepatocyte nuclear factor 4 alpha (HNF4α) should be treated as the discrete, druggable targets.
Not applicable to "hepatocyte nuclear transcriptional machinery" as a unified target. For HNF4α specifically, potential mechanisms would involve: - Modulation of its nuclear receptor/transcription factor activity to alter expression of metabolic and proliferation-related genes
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatocyte nuclear transcriptional machinery.